Previously, in the gliomas-related research by Leone et al. [46], patients with p18 (encoded by CDKN2C)-positive oligodendrogliomas have reduced OS and PFI times, which is the same as our findings in LGG based on univariate Cox regression analysis and log-rank test. This evidence concerns the gene CDKN2C and oligodendroglioma.